Abstract
Background: Acute cholangitis (AC) is a common emergency with a significant mortality risk. The Tokyo Guidelines (TG) provide recommendations for diagnosis, severity stratification, and management of AC. However, validation of the TG remains poor. This study aims to validate TG07, TG13, and TG18 criteria and identify predictors of in-hospital mortality in patients with AC. Methods: This is a retrospective audit of patients with a discharge diagnosis of AC in the year 2016. Demographic, clinical, investigation, management and mortality data were documented. We performed a multinomial logistic regression analysis with stepwise variable selection to identify severity predictors for in-hospital mortality. Results: Two hundred sixty-two patients with a median age of 75.9 years (IQR 64.8–82.8) years were included for analysis. TG13/TG18 diagnostic criteria were more sensitive than TG07 diagnostic criteria (85.1 vs. 75.2%; p < 0.006). The majority of the patients (n = 178; 67.9%) presented with abdominal pain, pyrexia (n = 156; 59.5%), and vomiting (n = 123; 46.9%). Blood cultures were positive in 95 (36.3%) patients, and 79 (83.2%) patients had monomicrobial growth. The 30-day, 90-day, and in-hospital mortality numbers were 3 (1.1%), 11 (4.2%), and 15 (5.7%), respectively. In multivariate analysis, type 2 diabetes mellitus (OR = 12.531; 95% CI 0.354–116.015; p = 0.026), systolic blood pressure <100 mm Hg (OR = 10.108; 95% CI 1.094–93.395; p = 0.041), Glasgow coma score <15 (OR = 38.16; 95% CI 1.804–807.191; p = 0.019), and malignancy (OR = 14.135; 95% CI 1.017–196.394; p = 0.049) predicted in-hospital mortality. Conclusion: TG13/18 diagnostic criteria are more sensitive than TG07 diagnostic criteria. Type 2 diabetes mellitus, systolic blood pressure <100 mm Hg, Glasgow coma score <15, and malignant etiology predict in-hospital mortality in patients with AC. These predictors could be considered in acute stratification and treatment of patients with AC.
References
1.
Kama
NA
, Atli
M
, Doganay
M
, Kologlu
M
, Reis
E
, Dolapci
M
. Practical recommendations for the prediction and management of common bile duct stones in patients with gallstones
. Surg Endosc
. 2001
Sep
;15
(9
):942
–5
.
[PubMed]
0930-27942.
Wang
Z
, Ahmed
S
, Shelat
VG
. Acute Cholangitis. In: Sartelli
M
, Bassetti
M
, Martin-Loeches
I
, editors. Abdominal Sepsis: A Multidisciplinary Approach
. Springer International Publishing
; 2018
. pp. 65
–81
. 3.
Andrew
DJ
, Johnson
SE
. Acute suppurative cholangitis, a medical and surgical emergency. A review of ten years experience emphasizing early recognition
. Am J Gastroenterol
. 1970
Aug
;54
(2
):141
–54
.
[PubMed]
0002-92704.
Wada
K
, Takada
T
, Kawarada
Y
, Nimura
Y
, Miura
F
, Yoshida
M
, et al. Diagnostic criteria and severity assessment of acute cholangitis: tokyo Guidelines
. J Hepatobiliary Pancreat Surg
. 2007
;14
(1
):52
–8
.
[PubMed]
0944-11665.
Kiriyama
S
, Takada
T
, Strasberg
SM
, Solomkin
JS
, Mayumi
T
, Pitt
HA
, et al.; Tokyo Guidelines Revision Committee
. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines
. J Hepatobiliary Pancreat Sci
. 2012
Sep
;19
(5
):548
–56
.
[PubMed]
1868-69746.
Kiriyama
S
, Kozaka
K
, Takada
T
, Strasberg
SM
, Pitt
HA
, Gabata
T
, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)
. J Hepatobiliary Pancreat Sci
. 2018
Jan
;25
(1
):17
–30
. Available from:
[PubMed]
1868-69747.
Sun
G
, Han
L
, Yang
YS
, Linghu
EQ
, Li
W
, Cai
FC
, et al. Verification of the Tokyo guidelines for acute cholangitis secondary to benign and malignant biliary obstruction: experience from a Chinese tertiary hospital
. Hepatobiliary Pancreat Dis Int
. 2013
Aug
;12
(4
):400
–7
.
[PubMed]
1499-38728.
Kiriyama
S
, Takada
T
, Hwang
TL
, Akazawa
K
, Miura
F
, Gomi
H
, et al. Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study
. J Hepatobiliary Pancreat Sci
. 2017
Jun
;24
(6
):329
–37
.
[PubMed]
1868-69749.
Mak
, M.
, Low
, J. K.
, Junnarkar
, S. P.
, Huey
, T.
, & Shelat
, V. G.
(2019
). A prospective validation of Sepsis-3 guidelines in acute hepatobiliary sepsis: qSOFA lacks sensitivity and SIRS criteria lacks specificity (Cohort Study). International journal of surgery (London, England), 72, 71–77. 10.
World Health Organization
. ICD-10: International statistical classification of diseases and related health problems: Tenth revision
. 5th ed. World Health Organization
; 2016
.11.
Shelat
VG
, Chia
CL
, Yeo
CS
, Qiao
W
, Woon
W
, Junnarkar
SP
. Pyogenic Liver Abscess: Does Escherichia Coli Cause more Adverse Outcomes than Klebsiella Pneumoniae?
World J Surg
. 2015
Oct
;39
(10
):2535
–42
.
[PubMed]
0364-231312.
Shelat
VG
, Wang
Q
, Chia
CL
, Wang
Z
, Low
JK
, Woon
WW
. Patients with culture negative pyogenic liver abscess have the same outcomes compared to those with Klebsiella pneumoniae pyogenic liver abscess
. Hepatobiliary Pancreat Dis Int
. 2016
Oct
;15
(5
):504
–11
.
[PubMed]
1499-387213.
Miura
F
, Okamoto
K
, Takada
T
, Strasberg
SM
, Asbun
HJ
, Pitt
HA
, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis
. J Hepatobiliary Pancreat Sci
. 2018
Jan
;25
(1
):31
–40
.
[PubMed]
1868-697414.
Tinusz
B
, Szapáry
L
, Paládi
B
, Tenk
J
, Rumbus
Z
, Pécsi
D
, et al. Short-Course Antibiotic Treatment Is Not Inferior to a Long-Course One in Acute Cholangitis: A Systematic Review
. Dig Dis Sci
. 2019
Feb
;64
(2
):307
–15
.
[PubMed]
0163-211615.
Dinc
T
, Kayilioglu
SI
, Coskun
F
. Evaluation and Comparison of Charcot’s Triad and Tokyo Guidelines for the Diagnosis of Acute Cholangitis
. Indian J Surg
. 2017
Oct
;79
(5
):427
–30
.
[PubMed]
0972-206816.
Tohda
G
, Ohtani
M
, Dochin
M
. Efficacy and safety of emergency endoscopic retrograde cholangiopancreatography for acute cholangitis in the elderly
. World J Gastroenterol
. 2016
Oct
;22
(37
):8382
–8
.
[PubMed]
1007-932717.
Yeo
CS
, Tay
VW
, Low
JK
, Woon
WW
, Punamiya
SJ
, Shelat
VG
. Outcomes of percutaneous cholecystostomy and predictors of eventual cholecystectomy
. J Hepatobiliary Pancreat Sci
. 2016
Jan
;23
(1
):65
–73
. Available from:
[PubMed]
1868-697418.
Kwan
JR
, Low
KS
, Lohan
R
, Shelat
VG
. Percutaneous transhepatic biliary drainage catheter fracture: A case report
. Ann Hepatobiliary Pancreat Surg
. 2018
Aug
;22
(3
):282
–6
. Available from:
[PubMed]
2508-577819.
Gornik
I
, Gornik
O
, Gasparović
V
. HbA1c is outcome predictor in diabetic patients with sepsis
. Diabetes Res Clin Pract
. 2007
Jul
;77
(1
):120
–5
.
[PubMed]
0168-822720.
Hatanaka
E
, Monteagudo
PT
, Marrocos
MS
, Campa
A
. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes
. Clin Exp Immunol
. 2006
Dec
;146
(3
):443
–7
.
[PubMed]
0009-910421.
Chia
CL
, Lee
AY
, Shelat
VG
, Ahmed
S
, Junnarkar
SP
, Woon
WW
, et al. Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?
Hepatobiliary Surg Nutr
. 2016
Feb
;5
(1
):38
–42
. Available from:
[PubMed]
2304-388122.
Kiat
TT
, Gunasekaran
SK
, Junnarkar
SP
, Low
JK
, Woon
W
, Shelat
VG
. Are traditional scoring systems for severity stratification of acute pancreatitis sufficient?
Ann Hepatobiliary Pancreat Surg
. 2018
May
;22
(2
):105
–15
. Available from:
[PubMed]
2508-577823.
Anbalakan
K
, Chua
D
, Pandya
GJ
, Shelat
VG
. (2015
). Five year experience in management of perforated peptic ulcer and validation of common mortality risk prediction models - are existing models sufficient? A retrospective cohort study. International journal of surgery (London, England), 14, 38–44. 24.
Danson
Y
, Yuan
TM
, Shelat
VG
. Pyogenic Liver Abscess. In: Sartelli
M
, Bassetti
M
, Martin-Loeches
I
, editors. Abdominal Sepsis: A Multidisciplinary Approach
. Springer International Publishing
; 2018
. pp. 83
–93
. 25.
Reynolds
BM
, Dargan
EL
. Acute obstructive cholangitis; a distinct clinical syndrome
. Ann Surg
. 1959
Aug
;150
(2
):299
–303
. Available from:
[PubMed]
0003-493226.
Schneider
J
, Hapfelmeier
A
, Thöres
S
, Obermeier
A
, Schulz
C
, Pförringer
D
, et al. Mortality Risk for Acute Cholangitis (MAC): a risk prediction model for in-hospital mortality in patients with acute cholangitis
. BMC Gastroenterol
. 2016
Feb
;16
(1
):15
.
[PubMed]
1471-230X27.
Singer
M
, Deutschman
CS
, Seymour
CW
, Shankar-Hari
M
, Annane
D
, Bauer
M
, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
. JAMA
. 2016
Feb
;315
(8
):801
–10
.
[PubMed]
0098-748428.
Seymour
CW
, Liu
VX
, Iwashyna
TJ
, Brunkhorst
FM
, Rea
TD
, Scherag
A
, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
. JAMA
. 2016
Feb
;315
(8
):762
–74
.
[PubMed]
0098-748429.
Goodacre
S
, Turner
J
, Nicholl
J
. (2006
). Prediction of mortality among emergency medical admissions.
Emergency medicine journal: EMJ, 23(5), 372–375. 30.
Grmec
S
, Gasparovic
V
. Comparison of APACHE II, MEES and Glasgow Coma Scale in patients with nontraumatic coma for prediction of mortality. Acute Physiology and Chronic Health Evaluation. Mainz Emergency Evaluation System
. Crit Care
. 2001
;5
(1
):19
–23
. Available from:
[PubMed]
1364-853531.
Maheshwari
K
, Nathanson
BH
, Munson
SH
, Khangulov
V
, Stevens
M
, Badani
H
, et al. The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients
. Intensive Care Med
. 2018
Jun
;44
(6
):857
–67
.
[PubMed]
0342-464232.
Shi
H
, Wan
J
, Xu
SP
, Liao
L
. [A retrospective analysis of clinical characteristics and mortality risks in elderly patients with acute cholecystitis and cholangitis]
. Zhonghua Nei Ke Za Zhi
. 2019
Jun
;58
(6
):415
–8
. Available from:
[PubMed]
0578-142633.
Tan
M
, Schaffalitzky de Muckadell
OB
, Laursen
SB
. Unchanged mortality in patients with acute cholangitis despite an increase in malignant etiologies - a 25-year epidemiological study
. Scand J Gastroenterol
. 2019
Mar
;54
(3
):335
–41
. Available from:
[PubMed]
0036-5521© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
